The Carlyle Group Inc. (CG) 13D/13G Filings for Reneo Pharmaceuticals, Inc. (RPHM)

The Carlyle Group Inc. 13D and 13G filings for Reneo Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-05-09
4:31 pm
Purchase		 2023-05-02 13D Reneo Pharmaceuticals, Inc.
RPHM		 Carlyle Group L.P.
CG		 273,046
8.200%		 64,250increase
(+30.77%)		 Filing
2022-08-11
4:52 pm
Purchase		 2022-08-01 13D Reneo Pharmaceuticals, Inc.
RPHM		 Carlyle Group L.P.
CG		 208,796
8.500%		 208,796increase
(New Position)		 Filing